Aktuelles zur rationellen Diagnostik und Therapie habitueller Frühaborte

M. K. Bohlmann; B. Schauf; D. W. Luedders; D. Wallwiener; T. Strowitzki; M. von Wolff

doi:10.1055/s-2006-955970

Geburtshilfe und Frauenheilkunde, Inhaltsverzeichnis

Geburtshilfe Frauenheilkd 2007; 67(3): 217-227
DOI: 10.1055/s-2006-955970

Übersicht

Georg Thieme Verlag KG Stuttgart · New York

Aktuelles zur rationellen Diagnostik und Therapie habitueller Frühaborte

Current Concepts of Efficient Diagnosis and Therapeutic Options in Patients with Recurrent Early AbortionsM. K. Bohlmann¹ , B. Schauf¹ , D. W. Luedders² , D. Wallwiener¹ , T. Strowitzki³ , M. von Wolff³

¹Universitäts-Frauenklinik Tübingen (Direktor: Prof. Dr. med. D. Wallwiener)
²Universitäts-Frauenklinik Lübeck (Direktor: Prof. Dr. med. K. Diedrich)
³Abteilung für Gynäkologische Endokrinologie & Fertilitätsstörungen (Direktor: Prof. Dr. med. T. Strowitzki), Universitäts-Frauenklinik Heidelberg

Abstract

Zusammenfassung

Habituelle Frühaborte, also mehr als zwei aufeinander folgende Fehlgeburten, betreffen etwa 1 - 2 % aller Partnerschaften. Traditionell werden chromosomale, anatomische, hämostaseologische, endokrine, autoimmunologische, infektionsbedingte sowie fraglich alloimmunologische Pathologien mit solchen habituellen Frühaborten assoziiert; jedoch wird bei fast 50 % der untersuchten Paare keine zugrunde liegende Abortursache gefunden. Die vorliegende Übersichtsarbeit soll einerseits Ansatzpunkte zur rationellen Diagnostik bei Paaren mit wiederholten Fehlgeburten liefern, zum anderen sollen verschiedene, zum Teil sehr umstrittene Therapieansätze auf dem Hintergrund aktueller Studien und Metaanalysen kritisch diskutiert werden.

Abstract

Recurrent early miscarriage, defined as more than two consecutive spontaneous abortions, affects 1 - 2 % of all couples. Traditionally, chromosomal, anatomic, hemostaseologic, endocrine, autoimmunologic, infectious and -hypothetically-alloimmunologic pathologies have been associated with recurrent abortion. However, in up to 50 % of cases, the underlying pathology remains unclear. It is the aim of this review to enhance the efficiency in the diagnosis of recurrent miscarriages. Furthermore, therapeutic options, including questionable methods, will be critically discussed on the basis of the latest studies and meta-analyses.

Schlüsselwörter

Frühschwangerschaft - habituelle Aborte - idiopathisch - rationelle Diagnostik - therapeutische Optionen

Key words

early pregnancy - recurrent abortion - idiopathic - efficient diagnosis - therapeutic options

Volltext

Referenzen

Literatur

1 Breckwoldt M, Keck C. Störungen der Fruchtbarkeit. Pfleiderer A, Breckwoldt M, Martius G Gynäkologie und Geburtshilfe, 3. Auflage. Stuttgart; Georg Thieme Verlag 2000
2 Berry C W, Brambati B, Eskes T K, Exalto N, Fox H, Geraedts J P, Gerhard I, Gonzales Gomes F, Grudzinskas J G, Hustin J. The Euro-Team Early Pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod. 1995; 10 1516-1520
3 Menge S, Müller-Lantzsch C, Keck C, Tempfer C. Recurrent spontaneous abortion: causes and therapeutic options. Geburtsh Frauenheilk. 2004; 64 574-583
4 Pandey M K, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005; 272 95-108
5 Rai R, Regan L. Recurrent miscarriage. Lancet. 2006; 368 601-611
6 Hassold T J, Jacobs P A. Trisomy in man. Annu Rev Genet. 1984; 18 69-97
7 Edmonds D K, Lindsay K S, Miller J F, Williamson E, Wood P J. Early embryonic mortality in women. Fertil Steril. 1982; 38 47-53
8 Creasy R. The cytogenetics of spontaneous abortion in humans. Beard RW, Sharp F Early Pregnancy Loss: Mechanisms and Treatment. London; Springer Verlag 1988: 293-304
9 Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000; 73 300-304
10 Voigt R, Axt-Fliedner R, Diedrich K, Schwinger E. Chromosomal findings in recurrent abortions. Gynäkol Endokrinol. 2005; 3 40-44
11 Stern J J, Dorfmann A D, Gutierrez-Najar A J, Cerrillo M, Coulam C B. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril. 1996; 65 250-253
12 Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril. 2001; 75 678-682
13 Christiansen O B, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod. 2002; 17 809-816
14 Stephenson M D, Awartani K A, Robinson W P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod. 2002; 17 446-451
15 Nawroth F, Strehler E, Sterzik K, Ludwig M. Habituelle Aborte - Diagnostik und Therapie. Frauenarzt. 2006; 47 300-304
16 Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 1997; 12 387-389
17 Nybo Andersen A M, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000; 320 1708-1712
18 Stirrat G M. Recurrent miscarriage. Lancet. 1990; 336 673-675
19 Steck T, Bussen S, Marzusch K. Strategien zur Abortprophylaxe bei einer Vorgeschichte mit wiederholten Fehlgeburten. I. Epidemiologie, genetische und anatomische Abortursachen. Fertilität. 1997; 13 7-16
20 von Wolff M, Strowitzki T. Recurrent miscarriages - a multifactorial disease. Gynäkol Endokrinol. 2005; 3 7-17
21 Robinson W P, McFadden D E, Stephenson M D. The origin of abnormalities in recurrent aneuploidy/polyploidy. Am J Hum Genet. 2001; 69 1245-1254
22 Knudsen U B, Hansen V, Juul S, Secher N J. Prognosis of a new pregnancy following previous spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 1991; 39 31-36
23 Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994; 9 1328-1332
24 Royal College of Obstetricians and Gynaecologists (RCOG) .Guideline No. 17. The management of recurrent miscarriage. London; Royal College of Obstetricians and Gynaecologists 1998
25 American College of Obstetricians and Gynecologists .Management of recurrent early pregnancy loss. ACOG practice bulletin. Washington DC; American College of Obstetricians and Gynecologists 2001
26 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. .Diagnostik und Therapie des wiederholten Spontanabortes (WSA), Leitlinien, Empfehlungen, Stellungnahmen, Stand September 2006. http://dggg.de/leitlinien-2006/pdf-2006/3-endo-fpm/3-2-3.wsa.pdf
27 Franssen M T, Korevaar J C, Leschot N J, Bossuyt P M, Knegt A C, Gerssen-Schoorl K B, Wouters C H, Hansson K B, Hochstenbach R, Madan K, van der Veen F, Goddijn M. Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ. 2005; 331 137-141
28 Christiansen O B, Andersen A MN, Bosch E, Daya S, Delves P J, Hviid T V, Kutteh W H, Laird S M, Li T C, van der Ven K. Evidenced-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005; 83 821-839
29 Goldenberg M, Sivan E, Sharabi Z, Mashiach S, Lipitz S, Seidman D S. Reproductive outcome following hysteroscopic management of intrauterine septum and adhesions. Hum Reprod. 1995; 10 2663-2665
30 Hickok L R. Hysteroscopic treatment of the uterine septum: a clinician's experience. Am J Obstet Gynecol. 2000; 182 1414-1420
31 Makino T, Umeuchi M, Nakada K, Nozawa S, Iizuka R. Incidence of congenital uterine anomalies in repeated reproductive wastage and prognosis for pregnancy after metroplasty. Int J Fertil. 1992; 37 167-170
32 Li T C, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Human Reprod Update. 2002; 8 463-481
33 Wölfler M M, Rimbach S. Morphologic uterine disorders in association with recurrent pregnancy loss. Gynäkol Endokrinol. 2005; 3 18-24
34 Grimbizis G, Camus M, Tarlatzis B C, Bontis J N, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001; 7 161-174
35 Salim R, Regan L, Woelfer B, Backos M, Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod. 2003; 18 162-166
36 Fedele L, Bianchi S, Marchini M, Mezzopane R, Di Nola G, Tozzi L. Residual uterine septum of less than 1 cm after hysteroscopic metroplasty does not impair reproductive outcome. Hum Reprod. 1996; 11 727-729
37 Marchionni M, Fambrini M, Zammbelli V, Scarselli G, Susini T. Reproductive performance before and after abdominal myomectomy: a retrospective analysis. Fertil Steril. 2004; 82 154-159
38 Plesinac S, Plecas D, Babovic I. Influence of uterine myomas on course and outcome of pregnancy. Geburtsh Frauenheilk. 2006; 66 674-676
39 Römer T. Post-abortion hysteroscopy - a method of early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol. 1994; 57 171-173
40 Dalton C F, Laird S M, Serle E, Saravelos H, Warren M A, Li T C, Bolton A E. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology. Hum Reprod. 1995; 10 2680-2684
41 Lessey B A, Castelbaum A J, Sawin A J, Sun J. Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril. 1995; 63 535-542
42 Aplin J D, Hey N A, Li T C. MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage. Am J Reprod Immunol. 1996; 35 261-266
43 Hambartsoumian E. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol. 1998; 39 137-143
44 Clifford K, Flanagan A M, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod. 1999; 14 2727-2730
45 Lim K J, Odukoya O A, Ajjan R A, Li T C, Weetman A P, Cooke I D. The role of T-helper cytokines in human reproduction. Fertil Steril. 2000; 73 136-142
46 von Wolff M, Thaler C J, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000; 6 627-634
47 von Wolff M, Strowitzki T, Stieger S, Becker V, Zepf C, Tabibzadeh S, Thaler C J. Osteopontin and its receptor β₃-integrin - mRNA and protein expression in human endometrium. Fertil Steril. 2001; 76 775-781
48 von Wolff M, Walter S, Jauckus J, Kern A, Strowitzki T. Glucose transporter proteins (GLUT) in human endometrium - does GLUT1 play a role in the endometrial preparation for the implanting embryo?. Hum Reprod. 2002; 17 131
49 Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril. 2005; 84 980-984
50 Kujovich J L. Thrombophilia and pregnancy complications. Am J Ob Gyn. 2004; 191 412-424
51 de Wolf F, Carreras L O, Moennan P. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 1982; 142 829-834
52 Out H J, Kooijman C D, Bruinse H W, Derksen R H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol. 1991; 41 179-186
53 Bane A L, Gillan J E. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003; 110 292-295
54 Rey E, Kahn S R, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003; 361 901-908
55 Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe G D, Walker I D, Greaves M, Brenkel I, Regan L, Greer I A. The Thrombosis: Risk and Economic Assessment of Thrombophila Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132 171-196
56 Ogasawara M S, Aoki K, Katano K, Ozaki Y, Suzumori K. Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril. 2001; 75 916-919
57 Pauer H U, Burfeind P, Kostering H, Emons G, Hinney B. Factor XII deficiency is strongly associated with primary recurrent abortions. Fertil Steril. 2003; 80 590-594
58 Gris J C, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood. 2002; 99 2606-2608
59 Marietta M, Facchinetti F, Sgarbi L, Simoni L, Bertesi M, Torelli G, Volpe A. Elevated plasma levels of factor VIII in women with early recurrent miscarriage. J Thromb Haemost. 2003; 1 2536-2539
60 Dossenbach-Glaninger A, van Trotsenburg M, Krugluger W, Dossenbach M R, Oberkanins C, Huber J, Hopmeier P. Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss. Thromb Haemost. 2004; 91 694-699
61 Willeke A, Gerdsen F, Bauersachs R, Lindhoff-Last E. Rationelle Thrombophiliediagnostik. Dtsch Ärztebl. 2002; 99 A2111-A2118
62 Buchholz T, Thaler C J. Inherited thrombophilia: impact on human reproduction. AJRI. 2003; 50 20-32
63 Rai R, Tuddenham E, Backos M, Jivraj S, El'Gaddal S, Choy S, Cork B, Regan L. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod. 2003; 18 2540-2543
64 Boushey C J, Beresford S AA, Omenn Motulsky G SAG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995; 274 1049-1057
65 Hübner U, Koch I, Retzke U, Herrmann W. Die Bedeutung der Hyperhomocysteinämie für Embryonalentwicklung und Schwangerschaftskomplikationen. Geburtsh Frauenheilk. 2003; 63 990-998
66 Makris M. Hyperhomocysteinemia and thrombosis. Clin Lab Haematol. 2000; 22 133-143
67 Nelen W L, Blom H J, Steegers E A, den Heijer M, Eskes T K. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000; 74 1196-1199
68 Bohlmann M K, von Wolff M, Rossmann H, Deckner C, Galler-Weber J, Strowitzki T. MTHFR-Polymorphismen und Homocysteinspiegel bei Paaren mit habituellen Aborten. Arch Gyn Obstet. 2004; 270 FV‐E 1.2-S 13
69 Bohlmann M K, Luedders D W, von Wolff M. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2007; 22 309
70 Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost. 2003; 1 433-438
71 Hills F A, Abrahams V M, Gonzalez-Timon B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam E W, Brosens J J. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod. 2006; 12 237-243
72 Gris J C, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland M L, Dauzat M, Mares P. Low-molecular-weight heparin versus lowdose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004; 103 3695-3699
73 Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. LIVE-ENOX Investigators . Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005; 3 227-229
74 Heilmann L, Rath W, von Tempfelhoff G F, Harenberg J, Breddin H K, Riess H, Schramm W. Niedermolekulare Heparine in der Schwangerschaft. Dtsch Ärztebl. 2002; 99 A424-432
75 Rath W, Heilmann L. Thrombophile Risikofaktoren und Schwangerschaftskomplikationen. Frauenarzt. 2002; 43 537-546
76 Meytes D, Ayalon H, Virag I, Weisbort, Zakut H. Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy. A case report. J Reprod Med. 1986; 31 993-996
77 Copplestone A, Oscier D G. Heparin-induced thrombocytopenia in pregnancy. Br J Haematol. 1987; 65 248
78 Greinacher A, Eckardt T, Mussmann J, Mueller-Eckardt C. Pregnancy complicated by heparin-associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (ORG 10172). Thromb Res. 1993; 71 123-126
79 Ginsberg J S, Hirsh J. Anticoagulans during pregnancy. Ann Rev Med. 1989; 40 79-86
80 Schinzel H, Bahlmann F, Peetz D, Savvidis S, Himmrich L, Klotz M. Prevention of thromboembolism with low-molecular weight heparin (Dalteparin-Na) in risk pregnancy. Med Klin. 2002; 97 193-203
81 Shefras J, Farquharson R G. Bone-densitity studie in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol. 1996; 65 171-174
82 Pettilä V, Kaaja R, Leinonen P, Ekblad U, Kataja M, Ikkala E. Thrombophylaxis with low-molecular weight heparin (Dalteparin) in pregnancy. Thromb Res. 1999; 96 275-282
83 Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005; 2 CD002859
84 Ogasawara M S, Iinuma Y, Aoki K, Katano K, Ozaki Y, Suzumori K. Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII. Fertil Steril. 2001; 76 203-204
85 Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002; 187 1623-1630
86 Slone D, Siskind V, Heinonen O P, Monson R R, Kaufman D W, Shapiro S. Aspirin and congenital malformations. Lancet. 1976; 26 1373-1375
87 Briggs S. Drugs in Pregnancy and Lactation: a Reference Guide to Fetal and Neonatal Risk. 5th ed. Baltimore, MD; Williams and Wilkins 1998: 73-81
88 Nielsen G L, Sorensen H T, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001; 322 266-270
89 Li D K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003; 327 368
90 Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. DACH-LIGA Homocystein e. V. . Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med. 2003; 41 1392-1403
91 Quere I, Mercier E, Bellet H, Janbon C, Mares P, Gris J C. Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia. Fertil Steril. 2001; 75 823-825
92 Rai R S, Regan L, Clifford K, Pickering W, Dave M, Mackie I, McInally T, Cohen H. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: result of a comprehensive screening approach. Hum Reprod. 1995; 10 2001-2005
93 Fialova L, Mikulikova L, Matous-Malbohan I, Benesova O, Zwinger A. Prevalence of various antiphospholipid antibodies in pregnant women. Physiol Res. 2000; 49 299-305
94 Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med. 2005; 129 61-68
95 Miyakis S, Lockshin M D, Atsumi T, Branch D W, Brey R L, Cervera R, Derksen R H, De Groot P G, Koike T, Meroni P L, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos P G, Krilis S A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4 295-306
96 Wilson W A, Gharavi A E, Koike T, Lockshin M D, Branch D W, Piette J C, Brey R, Derksen R, Harris E N, Hughes G R, Triplett D A, Khamashta M A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999; 42 1309-1311
97 Greaves M. Antiphospholipid antibodies and thrombosis. Lancet. 1999; 353 1348-1353
98 Luong T H, Rand J H, Wu X X, Godbold J H, Gascon-Lema M, Tuhrim S. Seasonal distribution of antiphospholipid antibodies. Stroke. 2001; 32 1707-1711
99 Sebire N J, Backos M, El Gaddal S, Goldin R D, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol. 2003; 101 258-263
100 Bose P, Black S, Kadyrov M, Bartz C, Shlebak Regan A L, Huppertz B. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol. 2004; 191 2125-2131
101 Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L, Huppertz B. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005; 192 23-30
102 Mak I Y, Brosens J J, Christian M, Hills F A, Chamley L, Regan L, White J O. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J Clin Endocrinol Metab. 2002; 87 2581-2588
103 Rai R, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995; 10 3301-3304
104 Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997; 314 253-257
105 di Simone N, Caliandro D, Castellani R, Ferrazzani S, de Carolis S, Caruso A. Low-molecular weight heparin restores invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod. 1999; 14 489-495
106 Empson M, Lassere M, Craig J C, Scott J R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol. 2002; 99 135-144
107 Sapir T, Blank M, Shoenfeld Y. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Ann N Y Acad Sci. 2005; 1051 743-778
108 Ober C, Karrison T, Odem R R, Barnes R B, Branch D W, Stephenson M D, Baron B, Walker M A, Scott J R, Schreiber J R. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet. 1999; 354 365-369
109 Scott J R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2003; 1 CD000112
110 Porter T, Lacoursiere Y, Scott J R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006; 19 CD000112
111 Shakhar K, Rosenne E, Loewenthal R, Shakhar G, Carp H, Ben-Eliyahu S. High NK cell activity in recurrent miscarriage: what are we really measuring?. Hum Reprod. 2006; 21 2421-2425
112 Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004; 329 1283-1285
113 Mills J L, Simpson J L, Driscoll S G, Jovanovic-Peterson L, Van Allen M, Aarons J H, Metzger B, Bieber F R, Knopp R H, Holmes L B. et al . Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988; 319 1617-1623
114 Rosenn B, Miodovnik M, Combs C A, Khoury J, Siddiqi T A. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994; 84 515-520
115 Hunger-Dathe W, Köhn B, Kloos C, Müller U A, Wolf G, Schleußner E. Prävalenz kindlicher Fehlbildungen bei Frauen mit einem präexistenten Diabetes mellitus in Abhängigkeit von der Stoffwechseleinstellung. Geburtsh Frauenheilk. 2005; 65 1147-1155
116 Lashen H, Fear K, Sturdee D W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19 1644-1646
117 Clark A M, Thornley B, Tomlinson L, Gattetley C, Norman R J. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998; 13 1502-1505
118 Morikawa M, Yamada H, Kato E H, Shimada S, Yamada T, Minakami H. Embryo loss pattern is predominant in miscarriages with normal chromosome karyotype among women with repeated miscarriage. Hum Reprod. 2004; 19 2644-2647
119 Jauniaux E, Farquharson R G, Christiansen O B, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006; 21 2216-2222
120 Ludwig M, Schulte H M. Thyroid gland in infertility patients, pregnancy and lactation. Gynäkol Endokrinol. 2005; 3 45-54
121 Roberts C P, Murphy A A. Endocrinopathies associated with recurrent pregnancy loss. Semin Reprod Med. 2000; 18 357-362
122 Vaquero E, Lazzarin N, De Carolis C, Valensise H, Moretti C, Ramanini C. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol. 2000; 43 204-208
123 Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002; 12 63-68
124 Bussen S S, Steck T. Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). Eur J Obstet Gynecol Reprod Biol. 1997; 74 139-143
125 Rushworth F H, Backos M, Rai R, Chilcott I T, Baxter N, Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod. 2000; 15 1637-1639
126 Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998; 70 246-252
127 Balasch J, Vanrell J A. Corpus luteum insufficiency and fertility: a matter of controversy. Hum Reprod. 1987; 2 557-567
128 Daya S, Ward S, Burrows E. Progesterone profiles in luteal phase defect cycles and outcome of progesterone treatment in patients with recurrent spontaneous abortion. Am J Obstet Gynecol. 1988; 158 225-232
129 McNeely M J, Soules M R. The diagnosis of luteal phase deficiency: a critical review. Fertil Steril. 1988; 50 1-15
130 Oates-Whitehead R M, Haas D M, Carrier J A. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2003; 4 CD003511
131 Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage - a reappraisal. Hum Reprod. 2000; 15 612-615
132 Clifford K, Rai R, Watson H, Franks S, Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ. 1996; 312 1508-1511
133 Craig L B, Ke R W, Kutteh W H. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril. 2002; 78 487-490
134 Jakubowicz D J, Iuorno M J, Jakubowicz S, Roberts K A, Nestler J E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87 524-529
135 Vanky E, Salvesen K A, Heimstad R, Fougner H J, Romundstad P, Carlson S M. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004; 19 1734-1740
136 Glueck C J, Awadalla S G, Phillips H, Cameron D, Wang P, Fontaine R N. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril. 2000; 74 394-397
137 Steck T, Bussen S, Marzusch K. Strategien zur Abortprophylaxe bei einer Vorgeschichte mit wiederholten Aborten. II. Infektionen, metabolische und endokrine Störungen, Schadstoffe und Gerinnungsdefekte. Fertilität. 1997; 13 17-26
138 Horne A W, Alexander C I. Recurrent miscarriage. J Fam Plann Reprod Health Care. 2005; 31 103-107
139 Ugwumade A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis. Lancet. 2003; 361 983-998
140 Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 1984; 148 140-146
141 Sugiura-Ogasawara M, Furukawa T A, Nakano Y, Hori S, Aoki K, Kitamura T. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod. 2002; 17 2580-2584
142 Arck P. Stress and embryo implantation. J Gynecol Obstet Biol Reprod (Paris). 2004; 33 S40-S42
143 Liddell H S, Pattison N S, Zanderigo A. Recurrent miscarriage-outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol. 1991; 31 320-322

Michael K. Bohlmann

Universitäts-Frauenklinik

Calwer Straße 7

72076 Tübingen

eMail: michael.bohlmann@med.uni-tuebingen.de